Didier Merlin
Impact in
- Pharmaceutical Science top 0.1%
- Advanced Drug Delivery Systems
- Physiology top 0.2%
Papers in
-
- RNA Interference and Gene Delivery 23
- Genetics 55
- Inflammatory Bowel Disease 43
- Co-authors
- Shanthi V. Sitaraman (91 shared papers)Émilie Viennois (54 shared papers)Mingzhen Zhang (32 shared papers)Bo Xiao (38 shared papers)Hamed Laroui (43 shared papers)Guillaume Dalmasso (40 shared papers)Andrew T. Gewirtz (38 shared papers)Yutao Yan (42 shared papers)
- Journals
- Gastroenterology (36 papers)American Journal of Physiology-Gastrointestinal and Liver Physiology (15 papers)Journal of Biological Chemistry (15 papers)Inflammatory Bowel Diseases (11 papers)PLoS ONE (9 papers)
- Partner nations
- United StatesChinaFrance
In The Last Decade
Didier Merlin
242 papers receiving 15.5k citations
Didier Merlin's Hit Papers
Peers
Comparison fields: 5 of 149
- Pharmaceutical Science 1.2k
- Physiology 683
- Cancer Research 2.0k
- Molecular Medicine 589
- Biomaterials 1.5k
Countries citing papers authored by Didier Merlin
This map shows the geographic impact of Didier Merlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Didier Merlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Didier Merlin more than expected).
Fields of papers citing papers by Didier Merlin
This network shows the impact of papers produced by Didier Merlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Didier Merlin. The network helps show where Didier Merlin may publish in the future.
Co-authors
The 25 scholars most cited alongside Didier Merlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 246 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer Hit paper breakdown → | 2016 | 760 |
| 2 | Orally delivered thioketal nanoparticles loaded with TNF-α–siRNA target inflammation and inhibit gene expression in the intestines Hit paper breakdown → | 2010 | 614 |
| 3 | 2007 | 395 | |
| 4 | 2016 | 357 | |
| 5 | 2009 | 335 | |
| 6 | 2012 | 272 | |
| 7 | 2016 | 251 | |
| 8 | 2017 | 251 | |
| 9 | 2005 | 233 | |
| 10 | 2009 | 208 | |
| 11 | 2004 | 206 | |
| 12 | 2016 | 201 | |
| 13 | 2018 | 196 | |
| 14 | 2003 | 195 | |
| 15 | 2016 | 194 | |
| 16 | 2017 | 189 | |
| 17 | 2000 | 178 | |
| 18 | 2001 | 177 | |
| 19 | 2008 | 176 | |
| 20 | 2014 | 171 |
About Didier Merlin
Didier Merlin is a scholar working on Molecular Biology, Genetics, Oncology, Cancer Research and Surgery, having authored 246 papers that have together received 15.7k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (43 papers), Drug Transport and Resistance Mechanisms (27 papers), RNA Interference and Gene Delivery (23 papers), Helicobacter pylori-related gastroenterology studies (23 papers), MicroRNA in disease regulation (21 papers), Adenosine and Purinergic Signaling (20 papers), Nanoparticle-Based Drug Delivery (19 papers) and Immune Response and Inflammation (16 papers). The work is most often cited by research in Pharmaceutical Science (1.2k citations), Physiology (683 citations), Cancer Research (2.0k citations), Molecular Medicine (589 citations) and Biomaterials (1.5k citations). Didier Merlin has collaborated with scholars based in United States, China and France. Frequent co-authors include Shanthi V. Sitaraman, Émilie Viennois, Mingzhen Zhang, Bo Xiao, Hamed Laroui, Guillaume Dalmasso, Andrew T. Gewirtz, Yutao Yan, Chunhua Yang and Hang Thi Thu Nguyen. Their work appears in journals such as Gastroenterology, American Journal of Physiology-Gastrointestinal and Liver Physiology, Journal of Biological Chemistry, Inflammatory Bowel Diseases and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.